Here are the facts on what patients could lose if HB 1150 becomes law and eliminates PBM-affiliated pharmacies including retail, specialty and home delivery.
Accredo has been helping patients access copay assistance programs for more than 10 years. Learn how copay assistance programs help patients access the care they need.
Listen to the latest episode of the Health Unscripted Podcast for a deep dive into the challenges and opportunities within the GLP-1 landscape.
Learn more about the large and fast-growing pipeline of oncology drugs and treatments and why specialized, personalized patient experiences are more important than ever.
Meet Dave, an Accredo patient living with common variable immune deficiency (CVID). With the support of Accredo's specialized team, Dave is better enabled to live life on his own terms.
Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is oversimplified and shortsighted.
Read the inspiring story of how Mary Beth Hull helped a customer navigate the overwhelming grief of losing a close family member.
• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible
• New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients